Repligen
RGEN
#1868
Rank
ยฃ8.34 B
Marketcap
ยฃ131.39
Share price
6.13%
Change (1 day)
17.91%
Change (1 year)
Categories

Repligen (RGEN) - Total debt

Total debt on the balance sheet as of June 2026 : ยฃ0.52 Billion

According to Repligen 's latest financial reports the company's total debt is ยฃ0.52 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Repligen - Total debt on balance sheet (from 2004 to 2026)

Total debt by year

Year Total debt Change
2025-12-31ยฃ0.51 B-6.31%
2024-12-31ยฃ0.54 B-2.12%
2023-12-31ยฃ0.55 B59.81%
2022-12-31ยฃ0.34 B28.92%
2021-12-31ยฃ0.27 B34.21%
2020-12-31ยฃ0.20 B0.62%
2019-12-31ยฃ0.20 B146.3%
2018-12-31ยฃ81.52 M11.02%
2017-12-31ยฃ73.43 M-4.89%
2016-12-31ยฃ77.21 M
2005-03-31ยฃ0.06 M37.95%
2004-03-31ยฃ0.04 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
ยฃ47.75 B 9,046.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ32.15 B 6,058.11%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ14.47 B 2,672.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ34.04 B 6,420.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ14.6 M-97.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.22 B-56.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ0.30 B-41.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ0.21 B-58.16%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ3.17 B 508.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ2.28 B 338.20%๐Ÿ‡บ๐Ÿ‡ธ USA